| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
MMV1801805
ID: ALA5314304
Chembl Id: CHEMBL5314304
Max Phase: Preclinical
Molecular Formula: C19H34N4O
Molecular Weight: 334.51
Associated Items:
Names and Identifiers
Canonical SMILES: CN1CCN(C2(CNC(=O)[C@H]3CC34CCNCC4)CCCC2)CC1
Standard InChI: InChI=1S/C19H34N4O/c1-22-10-12-23(13-11-22)19(4-2-3-5-19)15-21-17(24)16-14-18(16)6-8-20-9-7-18/h16,20H,2-15H2,1H3,(H,21,24)/t16-/m1/s1
Standard InChI Key: QGJFJPSIPRZAIH-MRXNPFEDSA-N
Alternative Forms
Associated Targets(non-human)
Plasmodium falciparum (966862 Activities)
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Calculated Properties
| Molecular Weight: 334.51 | Molecular Weight (Monoisotopic): 334.2733 | AlogP: 1.05 | #Rotatable Bonds: 4 |
| Polar Surface Area: 47.61 | Molecular Species: BASE | HBA: 4 | HBD: 2 |
| #RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 10.03 | CX LogP: 0.56 | CX LogD: -2.70 |
| Aromatic Rings: 0 | Heavy Atoms: 24 | QED Weighted: 0.81 | Np Likeness Score: -0.49 |
References
| 1. Bosc N, Felix E, Gardner JMF, Mills J, Timmerman M, Asveld D, Rensen K, Mukherjee P, Das R, Chenu E, Besson D, Burrows JN, Duffy J, Laleu B, Guantai EM, Leach AR.. (2023) MAIP: An Open-Source Tool to Enrich High-Throughput Screening Output and Identify Novel, Druglike Molecules with Antimalarial Activity., 14 (12): [PMID:38116432] [10.1021/acsmedchemlett.3c00369] |
Source
Source(1):